1. Home
  2. AERO vs ARQT Comparison

AERO vs ARQT Comparison

Compare AERO & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AERO

Grupo Aeromexico S.A.B.

N/A

Current Price

$19.41

Market Cap

3.1B

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$26.40

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AERO
ARQT
Founded
1934
2016
Country
Mexico
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AERO
ARQT
Price
$19.41
$26.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$30.83
$25.00
AVG Volume (30 Days)
331.0K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.31
EPS
N/A
N/A
Revenue
N/A
$196,542,000.00
Revenue This Year
$7.14
$86.38
Revenue Next Year
$4.82
$30.29
P/E Ratio
$7.95
N/A
Revenue Growth
N/A
229.74
52 Week Low
$16.00
$11.86
52 Week High
$23.05
$31.77

Technical Indicators

Market Signals
Indicator
AERO
ARQT
Relative Strength Index (RSI) 44.40 49.04
Support Level $18.91 $24.81
Resistance Level $19.66 $27.26
Average True Range (ATR) 1.12 1.19
MACD 0.04 0.06
Stochastic Oscillator 39.09 50.31

Price Performance

Historical Comparison
AERO
ARQT

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: